HPV Vaccination Among Young Adults in the US

HPV Vaccination Among Young Adults in the US

The human papillomavirus (HPV) vaccine was approved for females in 2006 and males in 2009 for the prevention of anogenital cancer and warts. The indications were expanded in 2020 to include the prevention of oropharyngeal cancer, which is more common in males. The Advisory Committee on Immunization...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2021-04, Vol.325 (16), p.1673-1674
Hauptverfasser: Chen, Michelle M, Mott, Nicole, Clark, Sarah J, Harper, Diane M, Shuman, Andrew G, Prince, Mark E. P, Dossett, Lesly A
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Age
Anogenital
Cancer
Female
Human papillomavirus
Humans
Immunization
Letter
Letters
Male
Males
Oropharyngeal cancer
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines
Patient Acceptance of Health Care - statistics & numerical data
Prevention
Research Letter
United States
Vaccination
Vaccination - statistics & numerical data
Vaccination - trends
Vaccines
Warts
Young Adult
Young adults
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The human papillomavirus (HPV) vaccine was approved for females in 2006 and males in 2009 for the prevention of anogenital cancer and warts. The indications were expanded in 2020 to include the prevention of oropharyngeal cancer, which is more common in males. The Advisory Committee on Immunization Practices recommends routine vaccination with 2 doses at age 11 to 12 years, with catch-up vaccination at age 13 to 26 years (limited to age 13-21 years from 2011 to 2019 for males).2 If the first dose occurs after age 15 years, a 3-dose series is recommended.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2021.0725